Who invested in Allakos?
Allakos's investors include Alta Partners, Roche Venture Fund, RiverVest, Novo Holdings and New Enterprise Associates, and 12 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$294Mraised across 5 rounds since 2012, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Reported by BiospaceSEC filing: $100M sold, first sale Nov 2017
From a historical funding recordSEC filing: $25M sold, first sale Dec 2012
From a historical funding recordSEC filing: $25M sold, first sale Dec 2012
Reported by sec.govSEC filing: $10.0M sold, first sale Dec 2012
From the SEC filings it signed: 2 on the team.
On the board, as filediDan JanneyJohn McKearnPaul WalkerSteve James
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Allakos's investors include Alta Partners, Roche Venture Fund, RiverVest, Novo Holdings and New Enterprise Associates, and 12 more on record.
Allakos has raised $294M across 5 rounds since 2012.
Allakos's most recent round was an Undisclosed round of $150M in Sept 2022.
Its most recent round, $150M in Sept 2022, is also its largest on record.
Allakos's first round on record, in Dec 2012, was backed by Alta Partners, De Novo Ventures and Roche Venture Fund and 2 others.
Allakos's latest named round is an Undisclosed round, in Sept 2022.
Allakos is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.